ArticleCancer pathogenesis and therapy2023

Commentary to "Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosomal biogenesis"☆.

No numbers read from the abstract.

Not cited yet